A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection

Clinical trial NCT02716428 · COMPLETED

Trial details

NCT number: NCT02716428
Sponsor: Trek Therapeutics, PBC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C Viral Infection Chronic Hepatitis C Hepatitis C (HCV)Hepatitis C Genotype 1

Start date: 2016-05-01
Primary completion: 2017-09-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.